Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$300.57 - $336.42 $57,408 - $64,256
-191 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$244.61 - $310.48 $1,956 - $2,483
-8 Reduced 4.02%
191 $58,000
Q4 2021

Jan 11, 2022

BUY
$198.21 - $248.9 $1,585 - $1,991
8 Added 4.19%
199 $49,000
Q3 2020

Oct 20, 2020

SELL
$140.89 - $159.9 $2,395 - $2,718
-17 Reduced 8.17%
191 $28,000
Q2 2020

Jul 14, 2020

SELL
$125.49 - $164.68 $3,513 - $4,611
-28 Reduced 11.86%
208 $32,000
Q4 2018

Jan 28, 2019

BUY
$108.23 - $136.84 $15,909 - $20,115
147 Added 165.17%
236 $26,000
Q3 2018

Nov 01, 2018

SELL
$123.14 - $138.52 $5,048 - $5,679
-41 Reduced 31.54%
89 $11,000
Q2 2018

Jul 18, 2018

SELL
$133.4 - $158.13 $1,334 - $1,581
-10 Reduced 7.14%
130 $17,000
Q1 2018

May 03, 2018

BUY
$138.75 - $176.72 $19,425 - $24,740
140 New
140 $20,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bedel Financial Consulting, Inc. Portfolio

Follow Bedel Financial Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.